Switch to:
Biomarin Pharmaceutical, Inc. (NAS:BMRN)
Cash And Cash Equivalents
$568.8 Mil (As of Dec. 2013)

Biomarin Pharmaceutical, Inc.'s quarterly cash and cash equivalents increased from Jun. 2013 ($175.4 Mil) to Sep. 2013 ($181.6 Mil) and increased from Sep. 2013 ($181.6 Mil) to Dec. 2013 ($568.8 Mil).

Biomarin Pharmaceutical, Inc.'s annual cash and cash equivalents increased from Dec. 2011 ($46.3 Mil) to Dec. 2012 ($180.5 Mil) and increased from Dec. 2012 ($180.5 Mil) to Dec. 2013 ($568.8 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical, Inc. Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 13.138.189.2228.3222.9167.288.146.3180.5568.8

Biomarin Pharmaceutical, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
BS_CashAndCashEquivalents 71.346.382.6177.8181.3180.5154.4175.4181.6568.8
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide